{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:16:45Z","timestamp":1788193005767,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.japh.2026.103485","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:44:12Z","timestamp":1783698252000},"page":"103485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Naloxone receipt following nonfatal opioid poisoning among Medicaid beneficiaries"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7961-3410","authenticated-orcid":false,"given":"Rasaq","family":"Oladapo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-6563","authenticated-orcid":false,"given":"Patricia R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-3433","authenticated-orcid":false,"given":"Daniel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-0326","authenticated-orcid":false,"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-5567","authenticated-orcid":false,"given":"Olufunmilola","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9-10","key":"10.1016\/j.japh.2026.103485_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/milmed\/usab485","article-title":"The public health approach to the worsening opioid crisis in the United States calls for harm reduction strategies to mitigate the harm from opioid addiction and overdose deaths","volume":"187","author":"Yeo","year":"2022","journal-title":"Mil Med"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/PHH.0000000000001391","article-title":"Strategy to action: incorporating cdc's 10 evidence-based strategies in overdose prevention and surveillance efforts","volume":"27","author":"Desai","year":"2021","journal-title":"J Public Health Management Pract"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","article-title":"The United States opioid epidemic","volume":"43","author":"Lyden","year":"2019","journal-title":"Semin Perinatol"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11606-019-05423-7","article-title":"Association of opioid overdose risk factors and naloxone prescribing in US adults","volume":"35","author":"Lin","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"SPP"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Subst Abuse"},{"key":"10.1016\/j.japh.2026.103485_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","article-title":"Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014Conception and maturation","volume":"178","author":"McDonald","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/CXA.0000000000000013","article-title":"Opioids on trial: a systematic review of interventions for the treatment and prevention of opioid overdose","volume":"9","author":"Bahji","year":"2018","journal-title":"Can J Addict"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/2042098614564776","article-title":"Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access","volume":"6","author":"Wermeling","year":"2015","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12954-023-00878-8","article-title":"Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department","volume":"20","author":"Ali","year":"2023","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.japh.2026.103485_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108785","article-title":"Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose","volume":"139","author":"Weiner","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jgs.18102","article-title":"High opioid doses, naloxone, and central nervous system active medications received by medicare-enrolled adults","volume":"71","author":"Silva Almod\u00f3var","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.japh.2026.103485_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajem.2020.10.061","article-title":"Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder","volume":"40","author":"Lane","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.japh.2026.103485_bib18","doi-asserted-by":"crossref","DOI":"10.1176\/appi.pn.2020.3b8","article-title":"Naloxone prescription fills inch upward, but remain low overall","volume":"55","author":"D'Arrigo","year":"2020","journal-title":"PN"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","article-title":"Naloxone and buprenorphine prescribing following US emergency department visits for suspected opioid overdose: august 2019 to April 2021","volume":"79","author":"Chua","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajad.13136","article-title":"A healthcare system-level intervention to increase naloxone availability for patients with opioid prescriptions","volume":"30","author":"Siff","year":"2021","journal-title":"Am J Addict"},{"key":"10.1016\/j.japh.2026.103485_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addbeh.2018.05.029","article-title":"Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users","volume":"86","author":"Schiavon","year":"2018","journal-title":"Addict Behav"},{"issue":"11","key":"10.1016\/j.japh.2026.103485_bib22","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/add.15854","article-title":"Are North Carolina clinicians delivering opioid use disorder treatment to medicaid beneficiaries?","volume":"117","author":"Grove","year":"2022","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jphs.12215","article-title":"Opioids in Georgia medicaid: gender and insurance disparities in utilization and potential inappropriate prescribing practices","volume":"9","author":"Jayawardhana","year":"2018","journal-title":"J Pharm Health Serv Res"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/AOG.0000000000003948","article-title":"Insurance-associated disparities in opioid use and misuse among patients undergoing gynecologic surgery for benign indications","volume":"136","author":"Huang","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.japh.2026.103485_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.4365","article-title":"Drug overdose deaths among medicaid beneficiaries","volume":"5","author":"Mark","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"9","key":"10.1016\/j.japh.2026.103485_bib26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/add.14634","article-title":"The impact of expanded medicaid eligibility on access to naloxone","volume":"114","author":"Frank","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.japh.2026.103485_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2018.05.014","article-title":"Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from medicaid","volume":"190","author":"Gertner","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103485_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108355","article-title":"Medicaid prescription limits and their implications for naloxone accessibility","volume":"218","author":"Roberts","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103485_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108888","article-title":"Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts, et al. 2021)","volume":"226","author":"Talbert","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"02","key":"10.1016\/j.japh.2026.103485_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4236\/pp.2024.152003","article-title":"Exploring the contribution of pharmacists in addressing the opioid crisis through naloxone prescriptions and pharmacist-led interventions","volume":"15","author":"Krey","year":"2024","journal-title":"Pharmacology & Pharmacy"},{"key":"10.1016\/j.japh.2026.103485_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/SAR.S351096","article-title":"The role of the pharmacist in combating the opioid crisis: an update","volume":"13","author":"Kosobuski","year":"2022","journal-title":"SAR"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajhp\/zxaa409","article-title":"Point-of-care naloxone distribution in the emergency department: a pilot study","volume":"78","author":"Moore","year":"2021","journal-title":"Am J Health-System Pharm"},{"key":"10.1016\/j.japh.2026.103485_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108588","article-title":"Race, ethnicity, and emergency department post-overdose care","volume":"131","author":"Reddy","year":"2021","journal-title":"J Substance Abuse Treat"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/08897077.2017.1356787","article-title":"Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone","volume":"39","author":"Okoro","year":"2018","journal-title":"Subst Abuse"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib35","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study","volume":"7","author":"Irvine","year":"2022","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1475-6773.13266","article-title":"Association between state medicaid expansion status and naloxone prescription dispensing","volume":"55","author":"Sohn","year":"2020","journal-title":"Health Serv Res"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jrh.12719","article-title":"Medicaid expansion and access to naloxone in metropolitan and nonmetropolitan areas","volume":"39","author":"Cheng","year":"2023","journal-title":"J Rural Health"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078592","article-title":"Retrospective study investigating naloxone prescribing and cost in US medicaid and medicare patients","volume":"14","author":"Manko","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.japh.2026.103485_bib39","article-title":"National increase but pronounced regional disparities in naloxone prescribing to United States medicaid and medicare patients","author":"Manko","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3209","article-title":"Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose","volume":"2","author":"Follman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib41","series-title":"Medicaid enrollment and unwinding tracker - Enrollment data","year":"2025"},{"key":"10.1016\/j.japh.2026.103485_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112915","article-title":"Cannabis use disorder risks among medicaid enrollees with comorbid psychiatric illnesses: 2012\u20132021","volume":"276","author":"Hou","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"01","key":"10.1016\/j.japh.2026.103485_bib45","doi-asserted-by":"crossref","first-page":"054","DOI":"10.1055\/s-0038-1673354","article-title":"Truven health analytics MarketScan databases for clinical research in Colon and rectal surgery","volume":"32","author":"Kulaylat","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jebm.12548","article-title":"Exploring patient medication adherence and data mining methods in clinical big data: a contemporary review","volume":"16","author":"Xu","year":"2023","journal-title":"J Evid Based Med"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(13)70324-4","article-title":"Strengthening the reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement","volume":"14","author":"Field","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.japh.2026.103485_bib48","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/add.16632","article-title":"Heightened mortality risk after a non-fatal opioid overdose: risk factors for mortality in the week following emergency treatment","volume":"119","author":"Eide","year":"2024","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.japh.2026.103485_bib49","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s11606-022-08014-1","article-title":"Opioid overdose risk following hospital discharge among individuals prescribed long-term opioid therapy: a risk interval analysis","volume":"38","author":"Lyden","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45691","article-title":"Factors associated with opioid overdose after an initial opioid prescription","volume":"5","author":"Weiner","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib51","series-title":"Naloxone Drugfacts","year":"2022"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/20476965.2019.1581433","article-title":"Key considerations when using health insurance claims data in advanced data analyses: an experience report","volume":"9","author":"Konrad","year":"2020","journal-title":"Health Syst"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib53","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.23889\/ijpds.v9i1.2407","article-title":"Secondary use of routinely collected administrative health data for epidemiologic research: answering research questions using data collected for a different purpose","volume":"9","author":"Emerson","year":"2024","journal-title":"IJPDS"},{"issue":"7","key":"10.1016\/j.japh.2026.103485_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf139","article-title":"Potential for error when relying on administrative data","volume":"112","author":"Zelicha","year":"2025","journal-title":"Br J Surg"},{"key":"10.1016\/j.japh.2026.103485_bib55","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","article-title":"Overview of emergency department visits in the United States, 2011","author":"Weiss","year":"2006"},{"key":"10.1016\/j.japh.2026.103485_bib56","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.45464","article-title":"Medicaid coverage and emergency department utilization in southeastern Pennsylvania","author":"Bakare","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib57","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s43441-019-00014-4","article-title":"Reducing patient burden in clinical trials through the use of historical controls: appropriate selection of historical data to minimize risk of bias","volume":"54","author":"Lim","year":"2020","journal-title":"Ther Innov Regul Sci"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1475-6773.12398","article-title":"Disease-specific trends of comorbidity coding and implications for risk adjustment in hospital administrative data","volume":"51","author":"Nimptsch","year":"2016","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"9","key":"10.1016\/j.japh.2026.103485_bib60","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1377\/hlthaff.2025.00253","article-title":"Medicaid enrollees with opioid use disorder were more likely to receive medication treatment than commercial enrollees: article examines opioid use disorder treatment for medicaid enrollees and commercial insurance enrollees","volume":"44","author":"Shen","year":"2025","journal-title":"Health Aff"},{"issue":"6","key":"10.1016\/j.japh.2026.103485_bib61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1377\/hlthaff.2019.01041","article-title":"Treatment of opioid use disorder among commercially insured US adults, 2008\u201317: study examines how medicare rural add-on payments affected the number of home health agencies serving rural counties","volume":"39","author":"Shen","year":"2020","journal-title":"Health Aff"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/722980","article-title":"Do policies to increase access to treatment for opioid use disorder work?","volume":"9","author":"Barrette","year":"2023","journal-title":"Am J Health Econ"},{"issue":"6","key":"10.1016\/j.japh.2026.103485_bib64","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","article-title":"Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy","volume":"10","author":"Park","year":"2016","journal-title":"J Addict Med"},{"issue":"13","key":"10.1016\/j.japh.2026.103485_bib65","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/ser0000099","article-title":"Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide","volume":"14","author":"Oliva","year":"2017","journal-title":"Psychol Serv"},{"issue":"10","key":"10.1016\/j.japh.2026.103485_bib67","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0968","article-title":"Evaluation of machine-learning algorithms for predicting opioid overdose risk among medicare beneficiaries with opioid prescriptions","volume":"2","author":"Lo-Ciganic","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1366161","article-title":"Overdose deaths before and during the COVID-19 pandemic in a US county","volume":"12","author":"Brown","year":"2024","journal-title":"Front Public Health"},{"issue":"2-3","key":"10.1016\/j.japh.2026.103485_bib72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","article-title":"Overdose after detoxification: a prospective study","volume":"89","author":"Wines","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2026.103485_bib73","series-title":"Non-fatal opioid overdose and associated health outcomes: Final summary report","year":"2019"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib74","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.12866","article-title":"Medicaid managed care naloxone coverage and management","volume":"8","author":"Feltus","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib75","series-title":"Medicaid access to naloxone: a look at state policies to removing barriers to access","author":"Forum","year":"2024"},{"key":"10.1016\/j.japh.2026.103485_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajem.2021.03.056","article-title":"Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal","volume":"47","author":"Kilaru","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"1;1","key":"10.1016\/j.japh.2026.103485_bib77","first-page":"31","article-title":"Patterns of long-term prescription opioid use among older adults in the United States: a study of medicare administrative claims data","volume":"24","year":"2021","journal-title":"Pain Phys"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cger.2021.07.001","article-title":"Screening for and management of opioid use disorder in older adults in primary care","volume":"38","author":"Duggirala","year":"2022","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"10.1016\/j.japh.2026.103485_bib79","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1111\/jgs.17408","article-title":"Naloxone prescribing to older adults in primary care","volume":"69","author":"Luther","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"suppl_1","key":"10.1016\/j.japh.2026.103485_bib80","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/geroni\/igae098.4012","article-title":"Knowledge gaps regarding naloxone use among older adults in high opioid prescribing regions in southern USA","volume":"8","author":"Azhar","year":"2024","journal-title":"Innovation in Aging"},{"issue":"suppl_1","key":"10.1016\/j.japh.2026.103485_bib81","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/geroni\/igae098.4375","article-title":"Addressing the high risk of opioid overdose among older adults: a retrospective chart review","volume":"8","author":"Kleykamp","year":"2024","journal-title":"Innov Aging"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib82","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.japh.2016.12.076","article-title":"Development of a targeted naloxone coprescribing program in a primary care practice","volume":"57","author":"Wilson","year":"2017","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib84","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.japh.2026.103485_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2016.11.003","article-title":"Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement","volume":"73","author":"Stumbo","year":"2017","journal-title":"J Substance Abuse Treat"},{"issue":"10","key":"10.1016\/j.japh.2026.103485_bib86","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/pm\/pnz304","article-title":"Prescription opioid misuse motives in US older adults","volume":"21","author":"Schepis","year":"2020","journal-title":"Pain Med"},{"issue":"10","key":"10.1016\/j.japh.2026.103485_bib87","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/pm\/pnz304","article-title":"Prescription opioid misuse motives in US older adults","volume":"21","author":"Schepis","year":"2020","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.japh.2026.103485_bib88","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1097\/j.pain.0000000000003589","article-title":"Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioids","volume":"166","author":"Wei","year":"2025","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003947","article-title":"Trajectories of prescription opioid dose and risk of opioid-related adverse events among older medicare beneficiaries in the United States: a nested case\u2013control study","volume":"19","author":"Wei","year":"2022","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib90","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in medicare part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib91","article-title":"Deprescribing in older adults with polypharmacy","volume":"385","author":"Hung","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12954-024-00973-4","article-title":"Older adult drug overdose: an application of latent class analysis to identify prevention opportunities","volume":"21","author":"Mason","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12913-021-07313-3","article-title":"Capitated versus fee-for-service reimbursement and quality of care for chronic disease: a US cross-sectional analysis","volume":"22","author":"Tummalapalli","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.japh.2026.103485_bib94","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2812","article-title":"Association between medicaid managed care coverage of substance use services and treatment utilization","volume":"3","author":"Auty","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.japh.2026.103485_bib95","series-title":"Prior authorization process policies in medicaid managed care: findings from a survey of state medicaid programs","author":"Raphael","year":"2025"},{"issue":"6","key":"10.1016\/j.japh.2026.103485_bib96","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18487","article-title":"Thematic analysis of state medicaid buprenorphine prior authorization requirements","volume":"6","author":"Nguemeni Tiako","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib97","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3132","article-title":"Association of formulary prior authorization policies with buprenorphine-naloxone prescriptions and hospital and emergency department use among medicare beneficiaries","volume":"3","author":"Mark","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103485_bib98","article-title":"Associations between copays, coverage limits for naloxone, and prescribing in medicaid","volume":"16","author":"Messinger","year":"2022","journal-title":"SubstAbuse"},{"key":"10.1016\/j.japh.2026.103485_bib99","article-title":"The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses","volume":"6","author":"Bohler","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"key":"10.1016\/j.japh.2026.103485_bib100","article-title":"Naloxone prescribing among long-term opioid-prescribed patients: disparities and opportunities","volume":"17","author":"Yorkgitis","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib101","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12954-022-00667-9","article-title":"Disparities in naloxone prescriptions in a University hospital during the COVID-19 pandemic","volume":"19","author":"Chieh","year":"2022","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.japh.2026.103485_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108569","article-title":"Patient, prescriber, and community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18","volume":"221","author":"Stein","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib103","first-page":"444","article-title":"Attitudes, beliefs, barriers, and facilitators of emergency department nurses toward patients with opioid use disorder and naloxone distribution","volume":"25","author":"Michels","year":"2024","journal-title":"West J Emerg Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","article-title":"Racial\/Ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York city","volume":"20","author":"Khan","year":"2023","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11606-025-09772-4","article-title":"Clinical decision support to increase naloxone Co-prescribing from the inpatient setting","volume":"41","author":"Lebin","year":"2026","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.japh.2026.103485_bib109","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5055\/jom.0887","article-title":"Pharmacist-initiated naloxone discharge prescribing for high-risk hospitalized internal medicine patients","volume":"20","author":"Wermers","year":"2024","journal-title":"J Opioid Manag"},{"issue":"6","key":"10.1016\/j.japh.2026.103485_bib110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.annemergmed.2018.01.052","article-title":"Opportunities for prevention and intervention of opioid overdose in the emergency department","volume":"71","author":"Houry","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.japh.2026.103485_bib111","article-title":"A narrative review on emergency management of poisoning","author":"Singh","year":"2023","journal-title":"JCDR"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib112","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-018-0117-1","article-title":"Emergency department screening and interventions for substance use disorders","volume":"13","author":"Hawk","year":"2018","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib113","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5811\/WESTJEM.35264","article-title":"Scoping review of adult emergency department discharge interventions","volume":"26","author":"Gorlick","year":"2025","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.japh.2026.103485_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111062","article-title":"Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021","volume":"255","author":"Rock","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.5547","article-title":"Core concepts in pharmacoepidemiology: key biases arising in pharmacoepidemiologic studies","volume":"32","author":"Acton","year":"2023","journal-title":"Pharmacoepidemiol Drug"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib116","article-title":"Predictors of non-transport by emergency medical services after a nonfatal opioid overdose: a national analysis","volume":"3","author":"Taylor","year":"2025","journal-title":"Health Aff Scholar"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib117","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/08897077.2019.1640832","article-title":"Who receives naloxone from emergency medical services? Characteristics of calls and recent trends","volume":"41","author":"Geiger","year":"2020","journal-title":"Subst Abuse"},{"key":"10.1016\/j.japh.2026.103485_bib118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.10.008","article-title":"Factors associated with naloxone administration in an opioid dependent sample","volume":"84","author":"Kenney","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.japh.2026.103485_bib119","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","article-title":"\u2018I have it just in case\u2019 \u2014 naloxone access and changes in opioid use behaviours","volume":"51","author":"Heavey","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.japh.2026.103485_bib120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/add.16686","article-title":"Predictors of emergency medical transport refusal following opioid overdose in Washington, DC","volume":"120","author":"Turley","year":"2025","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib121","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/14659891.2022.2070877","article-title":"Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: findings from a qualitative study","volume":"28","author":"Tofighi","year":"2023","journal-title":"J Subst Use"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib122","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0022042620945673","article-title":"Optimizing the distribution of pharmacy-dispensed naloxone using spatial mapping techniques in rural areas","volume":"50","author":"Banerjee","year":"2020","journal-title":"J Drug Issues"},{"issue":"S3","key":"10.1016\/j.japh.2026.103485_bib123","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","article-title":"Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities","volume":"105","author":"Faul","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.japh.2026.103485_bib124","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-065137","article-title":"Naloxone dispensing to youth ages 10\u201319: 2017\u20132022","volume":"154","author":"Terranella","year":"2024","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.japh.2026.103485_bib125","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30201","article-title":"Incidence and characteristics of nonfatal opioid overdose among youths aged 11 to 24 years by sex","volume":"3","author":"Bagley","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.japh.2026.103485_bib126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med"},{"key":"10.1016\/j.japh.2026.103485_bib127","article-title":"Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: findings from an environmental scan and key informant interviews","volume":"11","author":"Floyd","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"10.1016\/j.japh.2026.103485_bib128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.2024.307845","article-title":"Effect of the communities that HEAL intervention on overdose education and naloxone distribution: a cluster-randomized, wait-list controlled trial","volume":"115","author":"Freeman","year":"2025","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.japh.2026.103485_bib129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.17269\/s41997-024-00915-4","volume":"115","author":"Mbutiwi","year":"2024","journal-title":"Can J Public Health"},{"issue":"Spring","key":"10.1016\/j.japh.2026.103485_bib130","first-page":"1a","article-title":"Analyzing the ICD-10-CM transition and post-implementation stages: a public health institution case study","volume":"16","author":"Monestime","year":"2019","journal-title":"Perspect Health Inf Manag"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912600470X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912600470X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:38:23Z","timestamp":1788190703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912600470X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S154431912600470X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103485","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone receipt following nonfatal opioid poisoning among Medicaid beneficiaries","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"103485"}}